Comtech Prices Capital Complexity, Not the Cash Coming In

Summary: Comtech agreed to sell its satellite division for $157.5 million, more than twice its entire market capitalization. The market read the deal as distress. The filings say otherwise.

Why This Is the Best Opportunity Right Now

Comtech Telecommunications (NASDAQ: CMTL) closed at $2.40 on June 18, 2026, down 50% from $4.83 on June 12. The collapse followed a June 14 8-K announcing the sale of its Satellite and Space Communications segment to an affiliate of Gilat Satellite Networks for $157.5 million in cash, alongside amendments to both senior and subordinated credit facilities and an exchange of convertible preferred stock.

The market is pricing this as a fire sale. It is not. The sale price exceeds the equity market cap by roughly 2.2x. The retained business, Allerium, generated $10.4 million in quarterly Adjusted EBITDA. All major creditors and preferred holders agreed to terms that extend maturity runway and delay repurchase rights. The complexity of the capital structure is real, but the complexity is being confused with insolvency.

Why This Can Jump Or Dump More Than 5% Soon

Direction: up, on deal progression; down, on regulatory blockage.

The transaction requires HSR antitrust clearance and CFIUS approval, given the buyer is an affiliate of an Israeli company acquiring U.S. satellite and space communications assets. CFIUS reviews of satellite technology acquisitions by foreign buyers can extend or block deals. If CFIUS clears the transaction, the stock faces a re-rating as $157.5 million in cash moves from contingent to real. If CFIUS blocks it, the stock likely revisits the $1.80 area, its 52-week low.

Either outcome produces a move well beyond 5%. The catalyst window is the regulatory approval timeline, typically 3 to 6 months for CFIUS reviews of this nature. HSR clearance generally arrives faster.

What Should Surprise the Reader

The sale price is larger than the entire equity value. The market is valuing the common stock at approximately $71.8 million while the company is about to receive $157.5 million in cash from a single asset sale. Even after accounting for the subordinated debt make-whole penalty, the preferred stock liquidation preference, and remaining senior debt, the retained Allerium business is being priced near zero.

Opportunity Ranking

Rank	Idea	Discovery Lane	Why It May Be Best Now	Evidence Freshness	Catalyst Window	Near-Term >5% Move Case	Asymmetry	Main Reason to Reject
1	CMTL long common stock	Event-driven / special situation	Sale price 2.2x market cap; market prices complexity as distress	June 14-15, 2026 SEC filings; June 18 close	3-6 months (CFIUS + HSR)	CFIUS clearance or deal close triggers re-rating; failure sends to $1.80	Defined downside near 52w low; upside to $4-5 on deal close	Capital structure complexity; CFIUS risk
2	EXFY long common stock	Self-tender / modified Dutch auction	Tender completed at $1.20 ceiling; only $7.3M deployed of $25M authorized	June 12, 2026 SC TO-I/A	Immediate (post-tender settlement)	Tender settlement removes supply overhang; remaining $17.7M authorization unused	Moderate; stock already at $1.56 post-tender	Only 6.8% of shares tendered; company kept $17.7M unused
3	OPRT long common stock	Executive transition / CRO change	New CRO from PayPal with strong credit background; 18-year CCO departing	June 18, 2026 8-K	Medium-term (credit improvement)	New CRO appointment could improve credit outlook; slow burn	Limited; CEO transition not announced; $5.16 near 52w low	Transition is CCO/CRO level, not CEO; no revenue catalyst

Selected opportunity: CMTL long common stock

Why this one now: The dislocation is extreme. A $157.5 million cash sale on a $71.8 million market cap, with all creditors and preferred holders having agreed to improved terms, represents the kind of price-positioning-catalyst disagreement The Mispricing Desk is built to find. The market is pricing the wrapper (complex capital structure, segment divestiture, preferred overhang) rather than the contents (cash proceeds exceeding equity value, profitable retained business, expanding gross margins, five consecutive quarters of positive operating cash flow).

Why it can jump or dump >5% soon: CFIUS and HSR regulatory decisions on the Gilat affiliate acquisition are binary catalysts. Clearance triggers debt paydown and re-rating. Blockage triggers a return to 52-week lows.

What should surprise the reader: The preferred holders and subordinated lenders agreed to delay their repurchase and testing rights until 2027-2029. Stakeholders with the most information about the company's prospects chose to extend runway rather than accelerate repayment. That is not how creditors behave when they expect equity to be worthless.

The Setup

Comtech operates two segments: Allerium (terrestrial and wireless networks, public safety, 9-1-1 and NG9-1-1 solutions) and Satellite and Space Communications (S&S). On June 14, 2026, the company entered a Securities Purchase Agreement to sell the S&S business to Wavestream Corporation, a Delaware affiliate of Gilat Satellite Networks, for $157.5 million in cash, subject to working capital and other adjustments. A $10 million advance payment was made upon signing.

The same 8-K disclosed Amendment No. 4 to the senior credit agreement and Amendment No. 3 to the subordinated credit agreement. The senior amendment suspends covenant testing (fixed charge coverage, net leverage, minimum EBITDA) until the four-quarter period ending July 31, 2027, and fixes term loan margins at 9.5% over base rate and 10.5% over SOFR. The subordinated amendment modifies the make-whole on $65 million of term loans to 50% of principal before April 1, 2027 and 75% after, with a make-whole interest rate of 16%.

Magnetar Capital and White Hat Capital, the holders of 178,180.34 shares of Series B-3 Convertible Preferred Stock, agreed to exchange into Series B-4 Convertible Preferred Stock with the same $7.99 conversion price but with optional repurchase rights delayed to October 31, 2029 and cash dividend elections delayed to October 31, 2028.

The company also issued lender warrants for 625,000 shares of common stock at $0.10 exercise price, vesting October 17, 2026, unless the subordinated term loans are repaid before that date.

The Mispricing

The market appears to be pricing CMTL as a distress liquidation where the sale proceeds flow entirely to creditors and the common equity is residual value near zero. The evidence does not support this read.

The sale price of $157.5 million exceeds the common equity market capitalization of approximately $71.8 million by 2.2x. The retained Allerium business generated $55.7 million in Q3 revenue and $10.4 million in Adjusted EBITDA. Gross margin expanded to 34.0% from 30.7% year-over-year. The company reported its fifth consecutive quarter of positive operating cash flow at $6.1 million. Funded backlog stands at $696.1 million with approximately $1.1 billion in revenue visibility.

The variant perception: the market is pricing the complexity of the capital structure, not the cash coming in. The preferred holders and lenders agreed to extend their rights, not accelerate them. That behavior is inconsistent with a distress scenario and consistent with a negotiated restructuring that preserves equity value.

The alternative explanation: the market correctly prices the preferred stock overhang, the make-whole penalty, and the uncertainty of CFIUS approval. In this read, the common equity is fairly valued because the waterfall leaves little for common after debt, make-whole, and preferred claims.

The evidence supports a middle ground. The common equity is not worthless, but the ceiling is real. The preferred stock converts at $7.99, and above that price, roughly 11.9 million additional shares enter the float. The make-whole on $65 million of subordinated debt costs $32.5 million if repaid before April 2027. CFIUS approval is not guaranteed for a foreign acquisition of U.S. satellite technology assets.

Price

Metric	Value	Source
CMTL close (June 18, 2026)	$2.40	Yahoo Finance chart API
52-week range	$1.80 - $6.21	Yahoo Finance
Pre-announcement close (June 12)	$4.83	Yahoo Finance
4-day decline	-50.3%	Calculated
Market capitalization	~$71.8M	29.9M shares x $2.40
Sale price (S&S segment)	$157.5M	SEC 8-K, June 14, 2026
Sale/market cap ratio	~2.2x	Calculated
Cash (April 30, 2026)	$28.5M	10-Q balance sheet
Total liquidity	$49.4M	Q3 earnings release
Advance payment received	$10M	SEC 8-K
Q3 FY26 net sales	$106.0M	Q3 earnings release
Q3 FY26 Adjusted EBITDA	$8.2M	Q3 earnings release
Q3 gross margin	34.0%	Q3 earnings release
Q3 operating cash flow	$6.1M	Q3 earnings release
Funded backlog	$696.1M	Q3 earnings release
Revenue visibility	~$1.1B	Q3 earnings release

Timestamp: June 18, 2026, 20:00 UTC (June 19, 2026, 04:00 Singapore time). U.S. markets were closed June 19-20 (weekend). The next trading session is June 22, 2026.

Positioning

Live short interest and borrow data were not available in this research run. The stock traded 5.25 million shares on June 15, the day of the announcement, versus an average of roughly 300,000 shares in prior sessions. Volume remained elevated at 2.6 million on June 16 and 2.55 million on June 17. This volume spike suggests forced selling, institutional exit, or aggressive shorting on the announcement, not gradual repositioning.

The preferred stock holders (Magnetar and White Hat) are the most informed stakeholders. Their agreement to delay repurchase rights to October 2029 and cash dividends to October 2028 signals confidence in the post-sale capital structure. White Hat is affiliated with Mark Quinlan, a Comtech board member.

Magnetar received a board nomination right as part of the subordinated amendment. This gives the largest creditor direct governance oversight, aligning creditor and equity interests toward a successful transaction close rather than an acceleration scenario.

Missing positioning evidence: no live short interest, no borrow rate data, no options open interest or implied volatility data available. The thesis does not depend on a short squeeze, but elevated volume and a 50% price drop create conditions where short covering could amplify any positive catalyst.

Catalyst

Primary catalyst: CFIUS approval. The buyer is an affiliate of Gilat Satellite Networks, an Israeli company. The acquired business involves U.S. satellite and space communications technology, including U.S. government contracts. CFIUS reviews of foreign acquisitions of U.S. satellite technology are scrutinized. Clearance would unlock the $157.5 million and trigger debt paydown.

Secondary catalyst: HSR antitrust clearance. This typically arrives within 30 days of filing. The combination of Comtech S&S and Gilat in the satellite communications market could draw antitrust attention, though the businesses are largely complementary rather than overlapping.

Tertiary catalyst: Q4 FY2026 earnings, expected around September 2026. Post-close, the market would see Allerium as a standalone public safety company. Continued margin expansion, positive operating cash flow, or improved book-to-bill would support re-rating.

Reflexive mechanism: if the stock begins to recover, the 625,000 lender warrants at $0.10 exercise vest on October 17, 2026 (unless subordinated term loans are repaid first). If the term loans are repaid from sale proceeds, the warrants forfeit. This creates a narrow window where warrant holders may prefer the stock to rise before vesting, though the forfeit condition makes this a weak reflexive force.

What would accelerate: fast CFIUS clearance, debt paydown announcement, or guidance for the standalone Allerium business.

What would delay: extended CFIUS review, HSR second request, or regulatory conditions requiring divestitures.

What would invalidate: CFIUS blocking the transaction. In that scenario, Comtech retains the $10 million advance payment (subject to conditions) but loses the $147.5 million remaining proceeds. The stock likely revisits $1.80 or lower.

Payoff Map

The payoff is path-dependent on regulatory approval and debt paydown. The common equity value depends on three variables: (1) net cash remaining after sale proceeds, debt repayment, and make-whole penalties; (2) the market multiple assigned to Allerium as a standalone public safety business; (3) whether the preferred stock converts at $7.99 or remains outstanding.

Rough waterfall estimate (inference, not fact):

Sale proceeds: ~$145M net (after adjustments and transaction costs, estimated)
Subordinated debt repayment: $65M principal + $32.5M make-whole (50% before Apr 2027) = $97.5M
Remaining from sale: ~$47.5M
Plus existing cash: ~$28.5M
Plus $10M advance already received: included in cash
Senior debt paydown: unknown exact balance, estimated $60-100M
Remaining cash after debt paydown: $0-36M (wide range, insufficient data to narrow)

Allerium standalone valuation:

Annualized revenue: ~$223M (Q3 run-rate, adjusted for seasonality)
Annualized Adjusted EBITDA: ~$41.6M (Q3 run-rate, adjusted for prior-year comparison showing decline from $55.6M annualized)
Public safety technology comparable multiples: 5-8x EBITDA (inference, not verified against current peer set)
Implied Allerium enterprise value: $208M to $333M

Preferred stock: ~$95M liquidation preference, converts at $7.99 into ~11.9M shares. Post-conversion share count: ~42.4M (29.9M common + 11.9M conversion + 0.625M warrants).

Price Target and Probability Map

Scenario	Probability	Target / Level	Return / Payoff	Time Horizon	Conditions Required	Evidence Quality
Top Case	25%	$5.00	+108%	6-12 months	CFIUS clears; debt paid down; Allerium re-rates at 7x EBITDA; preferred converts at $7.99	Medium
Base Case	45%	$3.50	+46%	3-9 months	CFIUS clears with conditions; partial debt paydown; Allerium valued at 5x EBITDA	Medium
Bottom Case	25%	$1.80	-25%	1-3 months	CFIUS blocks or extends review; deal fails; stock revisits 52w low	Medium
Invalidation / Stop	5%	$1.50	-38%	Any	Deal termination; covenant breach; liquidity crisis	Low

Probability-weighted expected value: (0.25 x $5.00) + (0.45 x $3.50) + (0.25 x $1.80) + (0.05 x $1.50) = $1.25 + $1.575 + $0.45 + $0.075 = $3.35 versus current price of $2.40. Implied expected return: +39.6%.

Current market price / level: $2.40 (CMTL, June 18, 2026 close, Yahoo Finance)

Timestamp: June 18, 2026, 20:00 UTC (June 19, 2026, 04:00 Singapore time)

Primary instrument: CMTL common stock (NASDAQ)

Alternative expressions considered: CMTL call options were not verifiable in this run (insufficient live data on option chain, implied volatility, or open interest). Long common stock is the cleanest expression. A buyer of the common stock at $2.40 with a stop at $1.75 risks approximately 27% for a base-case 46% return and a top-case 108% return.

Confidence: Medium. The mispricing is structurally clear (sale price exceeds market cap), but the capital structure complexity creates a wide range of outcomes, and CFIUS approval is a genuine binary risk that I cannot quantify with available data.

What Would Prove This Wrong

CFIUS blocks or conditions the transaction to the point where the sale economics break down.
The senior term loan balance is materially larger than estimated, consuming most sale proceeds and leaving minimal cash for the equity.
Allerium Adjusted EBITDA continues to decline (Q3 was $10.4M versus $13.9M prior year), eroding the standalone business value.
The preferred stock holders exercise change-of-control or qualified asset sale repurchase rights despite the amended terms, accelerating claims ahead of common.
The company draws the revolver to fund operations during the regulatory review period, increasing net debt before sale proceeds arrive.

Risk Audit

Strongest counterargument: The capital structure is too complex for the common equity to have meaningful value. The preferred stock sits ahead of common with a ~$95M liquidation preference. The subordinated debt carries a $32.5M make-whole penalty. The senior debt balance is uncertain but likely $60-100M. After all claims, the common equity may be worth $1.50-2.00, not far from the current $2.40. The market is pricing the waterfall correctly, not mispricing complexity.

Most fragile assumption: The estimate of Allerium's standalone EBITDA multiple. If the market assigns 3-4x EBITDA instead of 5-7x, the equity value collapses. Public safety technology companies trade at varying multiples depending on growth, recurring revenue mix, and government contract concentration. I have not verified current peer trading multiples.

What the market may already know: The market may be pricing CFIUS risk more accurately than I am. Israeli acquisitions of U.S. satellite technology have faced scrutiny. The market may also know the exact senior debt balance, which I could not verify.

What could make the trade lose money even if the thesis is directionally right: The deal closes, debt is paid down, but Allerium's earnings continue to decline. Q3 Allerium EBITDA was $10.4M versus $13.9M prior year, a 25% decline. If that trend continues, the standalone business may not support a re-rating even after the capital structure simplifies.

Liquidity / execution risks: CMTL trades modest average volume (roughly 300K pre-announcement, 2-5M post-announcement). Bid-ask spreads may widen. The stock is volatile. Entry at $2.40 could face gap risk if news breaks outside market hours.

Leverage risks: The company is leveraged. Senior term loan margins are 9.5-10.5%. Subordinated make-whole interest rate is 16%. If the deal takes longer than expected, interest accrual consumes cash.

Information reliability risks: The preferred stock liquidation preference (~$95M) is estimated from dividend math, not confirmed from the Series B-4 Certificate of Designations. The senior term loan balance is not precisely known. The exact net sale proceeds after adjustments cannot be determined from available filings.

Invalidation trigger: A close below $1.75 would indicate the market is pricing deal failure or a worse-than-expected waterfall. Regulatory rejection or deal termination is a hard invalidation.

Publish / revise / reject recommendation: Publish as a speculative long with explicit acknowledgment of capital structure complexity and CFIUS binary risk. The asymmetry (defined downside near 52w low, 2.2x sale-to-market-cap ratio, creditor alignment) justifies publication despite uncertainty.

Bottom Line

Comtech is selling a division for more than twice its market capitalization. All creditors and preferred holders agreed to terms that extend runway rather than accelerate claims. The retained business generates $10.4 million in quarterly EBITDA with a $696 million backlog. The market priced the announcement as distress, cutting the stock 50% in four days. The mispricing is not that the capital structure is simple. It is not. The mispricing is that the market is valuing the complexity rather than the cash, the creditor alignment, and the retained earnings power. The trade fails if CFIUS blocks the deal or if the debt waterfall leaves less for common than the EBITDA multiple implies. The trade works if regulatory clearance arrives and the market re-rates Allerium as a standalone public safety company with a simplified balance sheet.

Best Trade Strategy

Direction: Long

Preferred instrument: CMTL common stock (NASDAQ: CMTL)

Common-stock stance: Long common stock is the primary expression. The stock trades at $2.40, near the lower end of its 52-week range ($1.80 - $6.21). Post-announcement volume has been elevated, providing sufficient liquidity for entry.

Options stance: Insufficient live data. I do not have reliable access to the CMTL option chain, implied volatility, open interest, or bid-ask spreads. If options are available, a long call spread (e.g., buy $3 call, sell $5 call) could express the thesis with defined risk, but this cannot be verified without live option data. Do not trade options without checking the chain first.

Entry reference: $2.30 - $2.50 (current market zone)

Take-profit:

Base case: $3.50 (45% return from $2.40)
Top case: $5.00 (108% return from $2.40)

Stop-loss / invalidation: $1.75 close (27% loss from $2.40). A close below $1.80 (52-week low) indicates the market is pricing deal failure or severe waterfall erosion.

Time horizon: 3 to 9 months. The catalyst is CFIUS and HSR regulatory decisions, plus Q4 FY2026 earnings (expected ~September 2026).

Execution risks:

Gap risk: regulatory news may break outside market hours
Volatility: 50% decline in 4 days implies elevated realized volatility
Liquidity: pre-announcement average volume was ~300K shares; post-announcement 2-5M; normal liquidity may return as the news ages
Bid-ask spread: use limit orders, do not cross the spread

Do-not-trade conditions:

If CFIUS formally requests an extended review or issues a national security concern letter before entry
If the company announces revolver draws that increase net debt beyond $15M
If Allerium reports a book-to-bill below 0.5x for two consecutive quarters (indicating revenue decline is structural, not timing)

Monitoring checklist:

CFIUS and HSR filing status (track via SEC 8-K filings and CFIUS public statements)
Senior term loan balance (next 10-Q, expected September 2026)
Allerium quarterly EBITDA and book-to-bill
Preferred stock holder actions (Magnetar, White Hat)
Revolver utilization
Gross margin trajectory (34.0% in Q3, trending up)

Research Quality Scorecard

Criterion	Score	Evidence Note
Market disagreement	5	Sale price 2.2x market cap; market prices complexity as distress while creditors extend runway
Evidence base	4	Fresh SEC 8-K (June 14) and 10-Q (June 15); Yahoo Finance prices; some balance sheet items estimated
Positioning and flows	3	Volume spike documented; creditor alignment evident from filings; no live short interest or borrow data
Catalyst path	4	CFIUS and HSR regulatory decisions are observable catalysts; timing uncertain but within 3-6 months
Payoff architecture	4	Defined downside near 52w low ($1.80); upside to $3.50-5.00; binary regulatory risk creates convexity
Invalidation discipline	4	Explicit stop at $1.75; CFIUS blockage as hard invalidation; monitoring checklist defined
Differentiated insight	5	Creditor alignment (delayed repurchase rights, covenant holidays) as a signal that informed stakeholders expect equity value preservation is non-obvious
Client value	4	Useful framework for evaluating post-restructuring equity even if the reader does not take the trade
Total	33/40

Sources

Source	Type	Access Date	Key Data
SEC 8-K, CMTL accession 0001104659-26-073803, filed June 15, 2026	Primary (Tier 1)	June 21, 2026	Sale agreement: $157.5M, $10M advance, CFIUS/HSR conditions, credit amendments, preferred exchange, warrants
SEC 10-Q, CMTL accession 0000023197-26-000069, filed June 15, 2026	Primary (Tier 1)	June 21, 2026	Balance sheet: assets $693.5M, liabilities $430.2M, cash $28.5M, equity $52.5M, shares 44.9M issued / 15.0M treasury
SEC 8-K, CMTL accession 0000023197-26-000070, filed June 15, 2026	Primary (Tier 1)	June 21, 2026	Q3 earnings release: revenue $106.0M, Adj EBITDA $8.2M, gross margin 34.0%, OCF $6.1M, backlog $696.1M
Yahoo Finance chart API, CMTL	Market data (Tier 2)	June 21, 2026	Close $2.40 (June 18), 52w range $1.80-$6.21, volume history
SEC XBRL companyfacts, CIK 0000023197	Primary (Tier 1)	June 21, 2026	Assets, liabilities, cash, equity, operating income as of April 30, 2026
Google News RSS, CMTL query	Media (Tier 3)	June 21, 2026	Headline confirmation: "Big Asset Sale Prompts A Bullish Response" (Seeking Alpha); Gilat acquisition coverage (SpaceNews)

Section 17 Quality Gate

Is the mispricing specific? Yes. Sale price exceeds market cap by 2.2x; market prices complexity as distress.
Is there evidence beyond narrative? Yes. SEC 8-K, 10-Q, earnings release, Yahoo Finance prices.
Is the positioning claim supported or clearly labeled as uncertain? Labeled uncertain. Volume spike documented; no live short interest or borrow data.
Is there a catalyst or plausible closing mechanism? Yes. CFIUS and HSR regulatory decisions.
Is the downside case described honestly? Yes. $1.80 bottom case; CFIUS blockage risk; EBITDA decline risk.
Is the strongest counterargument included? Yes. Capital structure complexity may mean the waterfall leaves little for common.
Is the article useful even if the trade is not taken? Yes. Framework for post-restructuring equity valuation.
Are all factual claims sourced or marked as unverified? Yes. Preferred liquidation preference marked as estimated; senior debt balance marked as unknown.
Does the article avoid hype? Yes.
Does the headline match the actual evidence? Yes. "Prices Capital Complexity, Not the Cash Coming In" directly references the mispricing.
Does the article explain why this is the best opportunity right now? Yes. Section: Why This Is the Best Opportunity Right Now.
Does the article explain why the selected asset can plausibly jump or dump more than 5% soon? Yes. Section: Why This Can Jump Or Dump More Than 5% Soon.
Does the article identify what should surprise a sophisticated reader? Yes. Section: What Should Surprise the Reader.
Does the article include top, base, and bottom targets with probabilities that add to 100%? Yes. 25/45/25/5 = 100%.
Does the main article file include its Research Quality Scorecard in a dedicated section? Yes.
Are all reader-facing tables kept as Markdown tables in the main article file? Yes.
If optional table images were explicitly requested, are they saved as separate packaging artifacts? Not applicable. No table images requested.
If the task required an illustration prompt, is it included inline? Yes. See below.
Does the main article file include a Best Trade Strategy section? Yes. Includes direction, instrument, entry, TP, SL, timeline, execution risks, do-not-trade conditions, monitoring checklist, options stance (insufficient data).
If the thesis uses technical signals, are they framed as timing/confirmation inputs? Not applicable. Thesis does not rely on technical signals.
Unless the user explicitly scoped the geography, did the research explicitly screen U.S., Japan, broader Asia, and Europe / UK lanes? User explicitly scoped to U.S. market long only. Geographic four-lane requirement waived per U.S.-only scope exception.
If the article uses Japan market as a lane or scope? Not applicable. User scoped to U.S.
If the user requested a live Substack finish? Not applicable. User did not request live Substack publish.

Illustration Prompt

A realistic, high-end editorial illustration for a financial publication cover. The scene depicts a satellite dish antenna, half dismantled and being lifted away by a construction crane, separating from a smaller, intact building labeled with a subtle 9-1-1 emergency symbol. The crane is depositing cash, represented as clean stacked bars, onto the smaller building's roof. The larger structure behind, now empty, casts a long shadow. The mood is tense but forward-looking. Color palette: deep navy blue background with warm amber and gold accents from the cash bars and crane lights. Style: photorealistic with slight editorial stylization, reminiscent of a Bloomberg Markets or Barron's cover feature. Composition: three-quarter perspective, the smaller building in foreground right, the crane and larger structure behind, dramatic lighting from the upper left. A subtle, semi-transparent watermark reading "The Mispricing Desk" appears in the lower right corner.